ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9701
-0.08%
Brent Oil
82.785
-0.41%
Bitcoin
64,203.36
0.32%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Geron Corp (GERN)

  7. Geron Corp (GERN) Noticias

GERN Geron Corp

3.94
-0.01 (-0.25%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Geron Corp GERN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.01 -0.25% 3.94 23:00:04
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.00 3.74 4.02 3.93 3.95
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202406:00BWGeron Corporation Reports First Quarter 2024 Financial..
25/4/202415:30BWGeron to Announce First Quarter 2024 Financial Results on..
18/4/202415:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
03/4/202415:30BWGeron to Participate at Upcoming Investor Conferences in..
19/3/202408:07BWGeron Corporation Announces Pricing of $150 Million..
14/3/202414:54BWGeron Announces FDA Oncologic Drugs Advisory Committee Votes..
28/2/202406:20EDGAR2Form 8-K - Current report
28/2/202406:05BWGeron Corporation Reports Business Highlights and Fourth..
22/2/202415:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
16/2/202415:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202416:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:30BWGeron to Announce Fourth Quarter and Full-Year 2023..
14/2/202407:44EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/1/202407:00EDGAR2Form 8-K - Current report
26/1/202410:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/1/202415:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
12/1/202407:30BWGeron to Participate in the B. Riley Securities Virtual..
08/1/202407:25EDGAR2Form 8-K - Current report
03/1/202418:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202418:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202418:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202315:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
15/12/202315:23EDGAR2Form 8-K - Current report
11/12/202315:15BWGeron Announces IMerge Phase 3 Presentations at ASH..
06/12/202307:00BWGeron Announces Fifty Percent Enrollment in the Phase 3..
04/12/202304:00BWGeron Announces Publication in The Lancet of Results from..
28/11/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202315:05EDGAR2Form 8-K - Current report
28/11/202307:00BWGeron Corporation Announces Appointment of Gaurav Aggarwal,..
16/11/202315:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
07/11/202315:30BWGeron to Participate at Upcoming Investor Conferences in..
02/11/202316:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/11/202308:00BWGeron IMerge Phase 3 Presentations at Upcoming ASH Annual..
02/11/202307:50EDGAR2Form 8-K - Current report
02/11/202307:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202307:00BWGeron Corporation Reports Business Highlights and Third..
26/10/202315:30BWGeron to Announce Third Quarter 2023 Financial Results on..
19/10/202315:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
02/10/202318:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202318:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202308:02EDGAR2Form 8-K - Current report
29/9/202307:00BWGeron Announces EMA Validation of Marketing Authorization..
27/9/202318:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202318:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/9/202319:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
GERN
Geron
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados